Search results for "Framing"

showing 10 items of 297 documents

Homocysteine and long-term recurrent infarction following an acute coronary syndrome.

2021

En Cardiology Journal. Gdańsk (Polonia) : Via Medica. Vol. 28, n. 4 (01 jul. 2021), pp. 598-606. ISSN 1897-5593. e-ISSN 1898-018X. Este artículo se encuentra disponible en la siguiente URL: https://journals.viamedica.pl/cardiology_journal/article/view/CJ.a2020.0170/52602 En este artículo de investigación también participan: Maria Marco, Teresa García-Ballester, Begoña Zorio, Eduardo Núñez, Francisco J. Chorro, Juan Sanchis y Julio Núñez. Background: There are no well-established predictors of recurrent ischemic coronary events after an acute coronary syndrome (ACS). Higher levels of homocysteine have been reported to be associated with an increased atherosclerotic burden. The primary endpoi…

Malemedicine.medical_specialtyAcute coronary syndromeHomocysteinemedicine.medical_treatmentCoronary heart disease - Risk factors.Infarto de miocardio - Factores de riesgo.Enfermedad coronaria - Factores de riesgo.InfarctionClinical CardiologyRevascularizationCoronary artery diseasechemistry.chemical_compoundInterquartile rangeRisk FactorsInternal medicineMyocardial infarction - Risk factors.medicineHumansMyocardial infarctionAcute Coronary SyndromeHomocysteineAgedacute coronary syndrome coronary artery disease homocysteine recurrent myocardial infarction risk factorsCardiovascular system - Diseases - Risk factors.Framingham Risk Scorebusiness.industryEnfermedades cardiovasculares - Factores de riesgo.General Medicinemedicine.diseaseHospitalizationchemistryCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiology journal
researchProduct

Insufficient control of heart rate in stable coronary artery disease patients in Latvia

2014

Background and objective:\ud Heart rate (HR) ≥70 beats per minute (bpm) increases cardiovascular risk in coronary artery disease (CAD) patients. The objective of the analysis is to characterize HR as well as other clinical parameters in outpatients with stable CAD in Latvia.<p></p>\ud \ud Materials and methods:\ud CLARIFY is an ongoing international registry of outpatients with established CAD. Latvian data regarding 120 patients enrolled in CLARIFY and collected at baseline visit during 2009–2010 were analyzed.<p></p>\ud \ud Results:\ud The mean HR was 67.7 ± 9.5 and 66.9 ± 10.7 bpm when measured by pulse palpation and electrocardiography, respectively. HR &#8…

Malemedicine.medical_specialtyAdrenergic beta-AntagonistsHeart rateCoronary artery diseaseAngina PectorisNOCoronary artery diseaseElectrocardiographyInternal medicineHeart ratemedicineHumansRegistriesCarvedilolAgedMetoprololHeart FailureMedicine(all)lcsh:R5-920Framingham Risk ScoreCoronary artery disease; Heart rate; Outpatient; Medicine (all)business.industryMedicine (all)OutpatientMiddle Agedmedicine.diseaseLatviaNebivololTreatment OutcomeBisoprololHeart failureAutomotive EngineeringCardiologycardiovascular systemFemalelcsh:Medicine (General)businessHeart rate; Coronary artery disease; Outpatienthuman activitiesmedicine.drugcirculatory and respiratory physiologyMedicina
researchProduct

Development of a Risk Score for Atrial Fibrillation in the Community; The Framingham Heart Study

2009

Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the condition, and to provide a framework for researchers to assess new risk markers.We assessed 4764 participants in the Framingham Heart Study from 8044 examinations (55% women, 45-95 years of age) undertaken between June, 1968, and September, 1987. Thereafter, participants were monitored for the first event of atrial fibrillation for a maximum of 10 years. Multivariable Cox regression identified clinical risk factors associated with development of atrial fibrillation in 10 years. Secondary analyses incorporated routine e…

Malemedicine.medical_specialtyAgingArticleSex FactorsFramingham Heart StudyRisk FactorsPredictive Value of TestsEpidemiologyAtrial FibrillationMedicineHumansLongitudinal StudiesRisk factorAgedProportional Hazards ModelsUltrasonographyAged 80 and overFramingham Risk ScoreHeart Murmursbusiness.industryCommunity ParticipationAbsolute risk reductionAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart failureHypertensionEmergency medicinePhysical therapyFemalebusinessCohort study
researchProduct

Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the F…

2005

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear transcription factor regulating multiple genes involved in lipid metabolism. It was shown that a common leucine to valine (L162V) substitution at the PPARalpha gene (PPARA) is functional and affects transactivation activity of PPARalpha ligands, such as PUFA, on a concentration-dependent basis. The current study examined this gene-nutrient interaction in relation to plasma lipid variables in a population-based study consisting of 1003 men and 1103 women participating in the Framingham cohort and consuming their habitual diets. We found significant gene-nutrient interactions between the L162V polymorphism and total PUF…

Malemedicine.medical_specialtyApolipoprotein BAlcohol DrinkingPopulationMedicine (miscellaneous)Peroxisome proliferator-activated receptorPolymorphism Single Nucleotidechemistry.chemical_compoundFramingham Heart StudyInternal medicinemedicineDiabetes MellitusHumansPPAR alphaeducationApolipoproteins CTriglycerideschemistry.chemical_classificationeducation.field_of_studyApolipoprotein C-IIISex CharacteristicsNutrition and DieteticsbiologyTriglycerideSmokingApolipoprotein C-IIILipid metabolismMiddle AgedDietary FatsEndocrinologychemistryAmino Acid SubstitutionCase-Control Studiesbiology.proteinFatty Acids Unsaturatedlipids (amino acids peptides and proteins)FemaleEnergy IntakePolyunsaturated fatty acidThe Journal of nutrition
researchProduct

P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).

2011

Long-term risk prediction is a priority for the prevention of atrial fibrillation (AF). P wave indices are electrocardiographic measurements describing atrial conduction. The role of P wave indices in the prospective determination of AF and mortality risk has had limited assessment. We quantified by digital caliper the P wave indices of maximum duration and dispersion in 1,550 Framingham Heart Study participants ≥ 60 years old (58% women) from single-channel electrocardiograms recorded from 1968 through 1971. We examined the association of selected P wave indices and long-term outcomes using Cox proportional hazards regression incorporating age, gender, body mass index, systolic blood press…

Malemedicine.medical_specialtyArticleElectrocardiographyFramingham Heart StudyPredictive Value of TestsRisk FactorsInternal medicineAtrial FibrillationMedicineHumansLongitudinal StudiesPR intervalRisk factorAgedProportional Hazards Modelsbusiness.industryProportional hazards modelIncidenceHazard ratioAtrial fibrillationMiddle Agedmedicine.diseaseConfidence intervalUnited StatesPhenotypeHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American journal of cardiology
researchProduct

Prevalence and characteristics of coronary artery disease in a population with suspected ischaemic heart disease using CT coronary angiography: corre…

2008

Purpose. This study was undertaken to describe the correlation between the distribution of coronary artery disease (CAD) in a symptomatic population with suspected ischaemic heart disease, cardiovascular risk factors (RF) and clinical presentation. Materials and methods. We studied 163 patients (mean age 65.5 years; 101 men and 62 women) referred for multidetector computed tomography coronary angiography (MDCT-CA) to rule out CAD. The patients had no prior history of revascularisation or myocardial infarction. We analysed how the characteristics of CAD (severity and type of plaque) can change with the increase in RF and how they are related to different clinical presentations. Results. Pati…

Malemedicine.medical_specialtyCT coronary angiographyPopulationMyocardial IschemiaCoronary Artery DiseaseCoronary AngiographySensitivity and SpecificityCoronary artery diseasePredictive Value of TestsInternal medicineEpidemiologyPrevalencemedicineHumansrisk factorsRadiology Nuclear Medicine and imagingMyocardial infarctioneducationAgedNetherlandsNeuroradiologyeducation.field_of_studyFramingham Risk Scoremedicine.diagnostic_testbusiness.industryReproducibility of Resultssuspected coronary artery diseaseInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseCT coronary angiography Risk factors Epidemiology Suspected coronary artery diseaseCardiologyFemaleepidemiologyPresentation (obstetrics)Tomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessRadiologia Medica
researchProduct

A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin.

2007

Patients with non-ST-elevation chest pain constitute a heterogeneous population. Our aim is to compare the outcome of patients with chest pain, non-ST-segment deviation, and normal troponin, categorized using a risk score, with that of patients with ST depression or troponin increase. A total of 1,449 patients with non-ST-elevation chest pain were evaluated. A validated risk score (using pain characteristics and risk factors) was applied to patients without ST depression or troponin increase. Accordingly, 4 risk categories were defined: group 1, no troponin increase, no ST depression, and risk score3 points (n = 633); group 2, no troponin increase, no ST depression, but risk scoreor = 3 poi…

Malemedicine.medical_specialtyChest painSeverity of Illness IndexAngina PectorisRisk categoryRisk FactorsInternal medicinemedicineMyocardial RevascularizationST segmentHumansAgedST depressionFramingham Risk Scorebiologybusiness.industryMiddle AgedPrognosisTroponinSurvival AnalysisTroponinHeterogeneous populationTreatment OutcomeSpainbiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Dietary fat interacts with the -514CT polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: th…

2003

We have previously reported an interaction between -514CT polymorphism at the hepatic lipase (HL) gene and dietary fat on high-density lipoprotein-cholesterol (HDL-C) metabolism in a representative sample of white subjects participating in the Framingham Heart Study. Replication of these findings in other populations will provide proof for the relevance and consistency of this marker as a tool for risk assessment and more personalized cardiovascular disease prevention. Therefore, we examined this gene-nutrient interaction in a representative sample of Singaporeans (1324 Chinese, 471 Malays and 375 Asian Indians) whose dietary fat intake was recorded by a validated questionnaire. When no str…

Malemedicine.medical_specialtyChinaGenotypeMedicine (miscellaneous)IndiaBiologyPolymerase Chain ReactionPolymorphism Single Nucleotidechemistry.chemical_compoundFramingham Heart StudyAsian PeopleInternal medicineGenotypeBlood plasmamedicineEthnicityHumansPromoter Regions GeneticTriglyceridesDNA PrimersNutrition and Dieteticsmedicine.diagnostic_testTriglycerideBase SequenceCholesterolConfoundingMalaysiaLipaseDietary FatsEndocrinologychemistryLiverFemaleHepatic lipaseLipid profileThe Journal of nutrition
researchProduct

Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects.

2008

Background— Whether mutations in the hemochromatosis (HFE) gene increase cardiovascular disease risk is still undetermined. The main reason is the low frequency of the mutations, in particular of the compound C282Y/H63D genotype. We combined the data of 11 observational studies for an individual patient data meta-analysis. Methods and Results— Individual patient data were obtained from published as well as unpublished studies that had information available on the C282Y mutation as well as the H63D mutation in relation to coronary heart disease risk. Individual records were provided on each of the 53 880 participants in 11 studies. In total, 10 541 patients with coronary events were documen…

Malemedicine.medical_specialtyCompound heterozygositymeta-analysicardiovascular diseases; epidemiology; meta-analysis; myocardial infarction; risk factorscardiovascular diseaseRisk FactorsInternal medicineEpidemiologyGenotypeGeneticsOdds RatioMedicineHumansGenetic Predisposition to DiseaseMyocardial infarctionHemochromatosis ProteinGenetics (clinical)HemochromatosisSettore MED/04 - Patologia GeneraleFramingham Risk Scorebusiness.industryHistocompatibility Antigens Class IMembrane ProteinsOdds ratioMiddle Agedmedicine.diseasemyocardial infarctionCardiovascular DiseasesMeta-analysisMutationCardiologyepidemiologyFemaleCardiology and Cardiovascular MedicinebusinessCirculation. Cardiovascular genetics
researchProduct

Control of hypertension in patients at high risk of cardiovascular disease.

2005

Background: Hypertension is a major cardiovascular risk factor, but knowledge about the real magnitude of the problem and its determinants is lacking. Aim: To assess control of hypertension and evaluate medical resource use, in patients at high risk of cardiovascular disease. Design: Multicentric cross-sectional study. Methods: We collected data for 2205 adult patients from 36 centres, representative of all regions of Spain. Patients had attended out-patient clinics from July 2002 to August 2003, had an absolute cardiovascular risk ⩾20% at 10 years (according to the Framingham guidelines), and had a diagnosis of hypertension. Pregnant and terminally ill patients were excluded. Results: Hype…

Malemedicine.medical_specialtyCross-sectional studyDiseaseRisk FactorsInternal medicineMedicineHumansIn patientRisk factorAntihypertensive AgentsAgedFramingham Risk Scorebusiness.industryGeneral MedicineHealth ServicesMiddle AgedCross-Sectional StudiesPoor controlCardiovascular DiseasesSpainHypertensionPhysical therapyResource useFemalebusinessBody mass indexQJM : monthly journal of the Association of Physicians
researchProduct